By elucidating the crucial involvement of the FGF21-KLB pathway in KD’s beneficial effects on hepatic steatosis, this study sheds light on the intricate interplay among dietary interventions, metabolic signaling pathways, and hepatic lipid metabolism. The gene discussed is FGF21; the disease is Hepatic steatosis.